Other Malignancies

In: Fertility Preservation in Oncological and Non-Oncological Diseases · 2020 · pp. 105–113 · doi:10.1007/978-3-030-47568-0_13 · W4238210812
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-08

This chapter presents less common diseases requiring fertility preservation in tabular form, detailing frequency, survival rates, gonadotoxicity, and metastasis risk to inform fertility preservation recommendations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This book chapter reviews less frequent diseases for which fertility preservation therapy may be indicated, presenting their frequency, 5-year survival rate, gonadotoxicity of oncologic treatments, and potential risk of gonadal metastases. It focuses on deriving fertility preservation recommendations across these conditions, covering roughly 80% of diseases needing fertility preservation, with details provided elsewhere for major disease categories. The chapter is limited by its nature as a synthesis/summary rather than an original clinical study, and it provides table-based information for uncommon conditions rather than detailed population-level outcomes for each. Relevance to endometriosis: the chapter includes a section title explicitly listing endometriosis among non-malignant diseases requiring stem cell transplantation, though the rest of this “Other Malignancies” content is focused on other malignancies and fertility preservation recommendations.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,642 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

In chapters “Breast Cancer, Hodgkin’s Lymphoma, Acute Leukaemia, Ovarian Tumours and Ovarian Cancer, Cervical Cancer, Endometrial Hyperplasia and Endometrial Carcinoma, Paediatric Oncological Cancer” and “Non-Malignant Diseases Requiring Stem Cell Transplantation; Severe Autoimmune Diseases; Endometriosis; Turner Syndrome; Transgender”, this book covers in detail approximately two-third of all diseases for which fertility preservation therapy is indicated. Other, but considerably less frequent diseases are presented in tabular form in this chapter in terms of their frequency, 5-year survival rate, gonadotoxicity of oncological treatment and the potential risk of gonadal metastases occurring. Recommendations for fertility preservation are derived from this. Overall, around 80% of the diseases requiring fertility preservation are described in this book. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Germeyer A, Dittrich R, Liebenthron J, Nawroth F, Sänger N, Suerdieck M, et al. FertiPROTEKT-Auswertungen 2018. J Reproduktionsmed Endokrinol. 2019;16:41–4. Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, et al. Fertility status among women treated for aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma. 2006;47:623–7. Gini G, Annibali O, Lupasco D, Bocci C, Tomarchio V, Sampaolo M, et al. Gonadal function recovery and fertility in women treated with chemo- and/or radiotherapy for Hodgkin’s and Non-Hodgkin lymphoma. Chemotherapy. 2019;64:36–41. Briseño-Hernández AA, Quezada-López DR, Castañeda-Chávez A, Dassaejv Macías-Amezcua M, Pintor-Belmontes JC. Bilateral ovarian Burkitt’s lymphoma. A case presentation. Cir Cir. 2014;82:212–8. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23:1007–13. Hoekman EJ, Smit VT, Fleming TP, Louwe LA, Fleuren GJ, Hilders CG. Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach. Fertil Steril. 2015;103:469–77. Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, et al. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305–14. Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12. Raciborska A, Bilska K, Filipp E, Drabko K, Rogowska E, Chaber R, et al. Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr Blood Cancer. 2015;62:341–5. Greve T, Wielenga VT, Grauslund M, Sørensen N, Christiansen DB, Rosendahl M, et al. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur J Cancer. 2013;49:1932–8. Abir R, Feinmesser M, Yaniv I, Fisch B, Cohen IJ, Ben-Haroush A, et al. Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod. 2010;25:1708–12. Dolmans MM, Iwahara Y, Donnez J, Soares M, Vaerman JL, Amorim CA, Poirel H. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients. Hum Reprod. 2016;31:2292–302. Sørensen SD, Greve T, Wielenga VT, Wallace WH, Andersen CY. Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing’s sarcoma. Future Oncol. 2014;10:277–83. Longhi A, Pignotti E, Versari M, Asta S, Bacci G. Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep. 2003;10:151–5. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, Dearnaley DP. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93:200–7. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2020 Springer Nature Switzerland AG About this chapter Cite this chapter von Wolff, M., Fey, M.F. (2020). Other Malignancies. In: von Wolff, M., Nawroth, F. (eds) Fertility Preservation in Oncological and Non-Oncological Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-47568-0_13 Download citation DOI: https://doi.org/10.1007/978-3-030-47568-0_13 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-47567-3 Online ISBN: 978-3-030-47568-0 eBook Packages: MedicineMedicine (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (13)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK